BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35836935)

  • 1. Molecular Modeling of ABHD5 Structure and Ligand Recognition.
    Shahoei R; Pangeni S; Sanders MA; Zhang H; Mladenovic-Lucas L; Roush WR; Halvorsen G; Kelly CV; Granneman JG; Huang YM
    Front Mol Biosci; 2022; 9():935375. PubMed ID: 35836935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Basis of ABHD5 Lipolysis Activation.
    Sanders MA; Zhang H; Mladenovic L; Tseng YY; Granneman JG
    Sci Rep; 2017 Feb; 7():42589. PubMed ID: 28211464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional insights into ABHD5, a ligand-regulated lipase co-activator.
    Tseng YY; Sanders MA; Zhang H; Zhou L; Chou CY; Granneman JG
    Sci Rep; 2022 Feb; 12(1):2565. PubMed ID: 35173175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ATGL lipase cooperates with ABHD5 to mobilize lipids for hepatitis C virus assembly.
    Vieyres G; Reichert I; Carpentier A; Vondran FWR; Pietschmann T
    PLoS Pathog; 2020 Jun; 16(6):e1008554. PubMed ID: 32542055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABHD5-A Regulator of Lipid Metabolism Essential for Diverse Cellular Functions.
    Schratter M; Lass A; Radner FPW
    Metabolites; 2022 Oct; 12(11):. PubMed ID: 36355098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perilipin controls lipolysis by regulating the interactions of AB-hydrolase containing 5 (Abhd5) and adipose triglyceride lipase (Atgl).
    Granneman JG; Moore HP; Krishnamoorthy R; Rathod M
    J Biol Chem; 2009 Dec; 284(50):34538-44. PubMed ID: 19850935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early onset of Chanarin-Dorfman syndrome with severe liver involvement in a patient with a complex rearrangement of ABHD5 promoter.
    Missaglia S; Valadares ER; Moro L; Faguntes ED; Quintão Roque R; Giardina B; Tavian D
    BMC Med Genet; 2014 Mar; 15():32. PubMed ID: 24628803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABHD5/CGI-58, the Chanarin-Dorfman Syndrome Protein, Mobilises Lipid Stores for Hepatitis C Virus Production.
    Vieyres G; Welsch K; Gerold G; Gentzsch J; Kahl S; Vondran FW; Kaderali L; Pietschmann T
    PLoS Pathog; 2016 Apr; 12(4):e1005568. PubMed ID: 27124600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism of the ichthyosis pathology of Chanarin-Dorfman syndrome: Stimulation of PNPLA1-catalyzed ω-O-acylceramide production by ABHD5.
    Ohno Y; Nara A; Nakamichi S; Kihara A
    J Dermatol Sci; 2018 Dec; 92(3):245-253. PubMed ID: 30527376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic interactions of ABHD5 with PNPLA3 regulate triacylglycerol metabolism in brown adipocytes.
    Yang A; Mottillo EP; Mladenovic-Lucas L; Zhou L; Granneman JG
    Nat Metab; 2019 May; 1(5):560-569. PubMed ID: 31497752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous and Synthetic ABHD5 Ligands Regulate ABHD5-Perilipin Interactions and Lipolysis in Fat and Muscle.
    Sanders MA; Madoux F; Mladenovic L; Zhang H; Ye X; Angrish M; Mottillo EP; Caruso JA; Halvorsen G; Roush WR; Chase P; Hodder P; Granneman JG
    Cell Metab; 2015 Nov; 22(5):851-60. PubMed ID: 26411340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis.
    Yu L; Li Y; Grisé A; Wang H
    Adv Exp Med Biol; 2020; 1276():197-222. PubMed ID: 32705602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5.
    Schweiger M; Lass A; Zimmermann R; Eichmann TO; Zechner R
    Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E289-96. PubMed ID: 19401457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chanarin-Dorfman syndrome: deficiency in CGI-58, a lipid droplet-bound coactivator of lipase.
    Yamaguchi T; Osumi T
    Biochim Biophys Acta; 2009 Jun; 1791(6):519-23. PubMed ID: 19061969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical roles for α/β hydrolase domain 5 (ABHD5)/comparative gene identification-58 (CGI-58) at the lipid droplet interface and beyond.
    Brown AL; Mark Brown J
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Oct; 1862(10 Pt B):1233-1241. PubMed ID: 28827091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of perilipin-5 (Plin5) with adipose triglyceride lipase.
    Granneman JG; Moore HP; Mottillo EP; Zhu Z; Zhou L
    J Biol Chem; 2011 Feb; 286(7):5126-35. PubMed ID: 21148142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of abhydrolase domain containing 5 gene (ABHD5) expression and variations on chicken fat metabolism.
    Ouyang H; Liu Q; Xu J; Zeng F; Pang X; Jebessa E; Liang S; Nie Q; Zhang X
    Poult Sci; 2016 Jan; 95(1):99-107. PubMed ID: 26574024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct roles for alpha-beta hydrolase domain 5 (ABHD5/CGI-58) and adipose triglyceride lipase (ATGL/PNPLA2) in lipid metabolism and signaling.
    Lord CC; Brown JM
    Adipocyte; 2012; 1(3):123-131. PubMed ID: 23145367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional interactions between Mldp (LSDP5) and Abhd5 in the control of intracellular lipid accumulation.
    Granneman JG; Moore HH; Mottillo EP; Zhu Z
    J Biol Chem; 2009 Jan; 284(5):3049-3057. PubMed ID: 19064991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A FRET sensor for the real-time detection of long chain acyl-CoAs and synthetic ABHD5 ligands.
    Mottillo EP; Mladenovic-Lucas L; Zhang H; Zhou L; Kelly CV; Ortiz PA; Granneman JG
    Cell Rep Methods; 2023 Feb; 3(2):100394. PubMed ID: 36936069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.